GlassScriptPhysician profile
Jason T Banks
NPI 1275534539
$64,749.69
in general payments reported to CMS, 2019-2025
14 companies · $5,189 in 2025
The $5,189 reported for 2025 was more than what 81% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $167 · 2021: $15.40 · 2022: $145 · 2023: $628 · 2024: $297 · 2025: $5,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5,074 · Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,074.39 |
| Food and Beverage | $1,039.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| North Alabama Surgical Services, LLC | $57,408.00 | 2019 | |
| Curiteva, INC. | $6,662.46 | 2019-2025 | |
| Si-Bone, INC. | $197.87 | 2022-2025 | |
| Providence Medical Technology, INC. | $187.52 | 2024-2025 | |
| Abbvie INC. | $68.29 | 2025 | |
| Spinal Elements, INC. | $37.77 | 2024 | |
| Abbott Laboratories | $33.88 | 2022 | |
| Arteriocyte Medical Systems, INC. | $32.20 | 2022 | |
| Prime Surgical, LLC | $29.44 | 2024 | |
| Integra Lifesciences Corporation | $24.72 | 2022 | |
| Stryker Corporation | $19.62 | 2019 | |
| Acadia Pharmaceuticals INC | $18.99 | 2023 | Nuplazid |
| Zimmer Biomet Holdings, INC. | $15.40 | 2021 | |
| Wenzel Spine, INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Banks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.